Zhongda Hospital Southeast University — Biomedical Watch V2

Essais liés8clinical trials

VilleNanjinglocalisation

PaysChinalocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07575672

Ouvrir le site du centre

Essais cliniques associés

8

Molécule	Indication / population	Phase	NCT	Titre	Statut
Survodutide	Maladie rénale chronique	Phase 3	NCT06077864	A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)	COMPLETED
Maridebart cafraglutide	Insuffisance cardiaque	Phase 3	NCT07037459	MARITIME-HF — Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity	RECRUITING
Selatogrel	Maladie coronarienne	Phase 3	NCT04957719	SOS-AMI — Selatogrel Outcome Study in Suspected Acute Myocardial Infarction	ENROLLING_BY_INVITATION
Qishen Yiqi dripping pills 4 bags/time	Insuffisance cardiaque	Phase 2	NCT04944706	Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction	COMPLETED
Vicadrostat	Insuffisance cardiaque	Phase 3	NCT06935370	A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart	RECRUITING
Finerenone	Insuffisance cardiaque	Phase 3	NCT07575672	FINE-VALUE — Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure	RECRUITING
Skeletal muscle biopsy (residual specimen)	Myopathies	À vérifier	NCT06101940	Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (C-DMCOS-DM1)	ENROLLING_BY_INVITATION
Vicadrostat	Hypertension	Phase 3	NCT07064473	EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	RECRUITING